EP.12A.22 Aumolertinib with Chemotherapy as First-Line Treatment in Patients with EGFR-Mutated Advanced NSCLC: A Real-World Study
Back to course
Pdf Summary
Asset Subtitle
Jiali Xu
Meta Tag
Speaker Jiali Xu
Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy
Keywords
aumolertinib
EGFR-mutated
NSCLC
first-line treatment
chemotherapy
progression-free survival
overall survival
adverse events
FLAURA2 study
real-world study
Powered By